Bio-Techne Corp Files 8-K on Operations and Financials
Ticker: TECH · Form: 8-K · Filed: Aug 7, 2024 · CIK: 842023
| Field | Detail |
|---|---|
| Company | Bio-Techne Corp (TECH) |
| Form Type | 8-K |
| Filed Date | Aug 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, filing
TL;DR
Bio-Techne dropped an 8-K detailing financials and operations. Check it out.
AI Summary
Bio-Techne Corporation filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition, as well as other events. The filing also includes financial statements and exhibits. The company, previously known as Techne Corp /MN/, is incorporated in Minnesota and headquartered in Minneapolis.
Why It Matters
This 8-K filing provides crucial updates on Bio-Techne's operational and financial performance, which can influence investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a standard operational and financial update, not indicating any immediate or significant risks.
Key Players & Entities
- BIO-TECHNE Corporation (company) — Registrant
- Techne Corp /MN/ (company) — Former Company Name
- Minnesota (location) — State of Incorporation
- Minneapolis (location) — Principal Executive Offices City
- 614 McKinley Place NE (address) — Principal Executive Offices Street
- 55413 (zip_code) — Principal Executive Offices Zip Code
- 6123798854 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Bio-Techne Corporation?
The primary purpose is to report on the company's results of operations and financial condition, as well as other events, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on August 7, 2024.
What was Bio-Techne Corporation's former name?
Bio-Techne Corporation's former name was Techne Corp /MN/.
In which U.S. state is Bio-Techne Corporation incorporated?
Bio-Techne Corporation is incorporated in Minnesota.
What is the address of Bio-Techne Corporation's principal executive offices?
The address of Bio-Techne Corporation's principal executive offices is 614 McKinley Place NE, Minneapolis, Minnesota 55413.
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 13.7 · Accepted 2024-08-07 06:32:25
Filing Documents
- tech-20240807x8k.htm (8-K) — 35KB
- tech-20240807xex99d1.htm (EX-99.1) — 603KB
- tech-20240807xex99d2.htm (EX-99.2) — 21KB
- 0001558370-24-011193.txt ( ) — 816KB
- tech-20240807.xsd (EX-101.SCH) — 3KB
- tech-20240807_lab.xml (EX-101.LAB) — 15KB
- tech-20240807_pre.xml (EX-101.PRE) — 11KB
- tech-20240807x8k_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition A copy of the press release issued by Bio-Techne Corporation on August 7, 2024, describing the results of operations for the quarter and year ended June 30, 2024, and its financial condition as of June 30, 2024 is attached hereto as Exhibit 99.1. The information in this Form 8-K and the Exhibits attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Other Events
Item 8.01 Other Events A copy of the press release issued by Bio-Techne Corporation on August 7, 2024 announcing a cash dividend is attached hereto as Exhibit 99.2.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits 99.1 Press Release, dated August 7, 2024, announcing results of operations 99.2 Press Release, dated August 7, 2024, announcing cash dividend 104 - Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-TECHNE CORPORATION Date: August 7, 2024 By: /s/ Shane V. Bohnen Shane V. Bohnen Senior Vice President, General Counsel and Secretary